Envoy Medical (COCH) Consolidated Net Income (2021 - 2026)

Envoy Medical has disclosed Consolidated Net Income across 6 years of filings, most recently posting -$6.0 million for Q1 2026.

• Consolidated Net Income for Q1 2026 came in at -$6.0 million, down 6.37% year-over-year; the trailing twelve-month figure through Mar 2026 was -$24.2 million (down 16.68% YoY), and the FY2025 annual result was -$23.9 million, down 18.87% from the prior year.
• Consolidated Net Income came in at -$6.0 million for Q1 2026 at Envoy Medical, up from -$6.4 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $12.5 million in Q1 2022 to a low of -$6.7 million in Q4 2023.
• The 5-year median for Consolidated Net Income is -$4.9 million (2024), against an average of -$2.4 million.
• Across the five-year window, Consolidated Net Income jumped 1400.18% in 2022 and slumped 785.52% in 2024, its largest moves.
• Envoy Medical's Consolidated Net Income stood at -$1.7 million in 2022, then plunged by 299.5% to -$6.7 million in 2023, then increased by 26.63% to -$4.9 million in 2024, then decreased by 29.43% to -$6.4 million in 2025, then climbed by 6.67% to -$6.0 million in 2026.
• The last three Consolidated Net Income figures came in at -$6.0 million (Q1 2026), -$6.4 million (Q4 2025), and -$6.2 million (Q3 2025), per Business Quant data.